Professor Shaun Jackson is an NHMRC Senior Principal Research Fellow, faculty member at the prestigious Scripps Research Institute in La Jolla, San Diego (CA, USA), and recently (2019) appointed to the title of Honorary Visiting fellow at the University Cambridge, School of Clinical Medicine, within the Department of Haematology.
Professor Jackson established his independent research laboratory in the Monash Department of Medicine at Box Hill Hospital in Victoria (1998–2003). In 2004 he moved to the Alfred Medical Research and Education Precinct, where he co-founded and became Research Director of the Australian Centre for Blood Diseases. He is a founder of Kinacia, an Australian biotechnology company developing novel diagnostic and therapeutic products aimed at preventing blood clotting. In 2013, he was appointed the inaugural Director of Cardiovascular Research, HRI & Charles Perkins Centre, The University of Sydney, where he remains to this day. He is also Research Director of Atherothrombosis Services within the Department of Cardiology at the Royal Prince Alfred (RPA) Hospital.
Professor Jackson’s research interests are focused in the area of atherothrombosis and cardiovascular disease.